Cargando…

Genetic Risk of Severe Covid-19

Detalles Bibliográficos
Autor principal:	Kaser, Arthur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583681/ https://www.ncbi.nlm.nih.gov/pubmed/33053291 http://dx.doi.org/10.1056/NEJMe2025501

Ejemplares similares

Genetic Variation, Diet, Inflammation, and the Risk for COVID-19
por: Simopoulos, Artemis P.
Publicado: (2021)

Sleep and circadian phenotypes: risk factors for COVID-19 severity?
por: Gao, Lei, et al.
Publicado: (2022)

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
por: Horst, Sara
Publicado: (2021)

Is severe COVID-19 pneumonia a typical or atypical form of ARDS? And does it matter?
por: Goligher, Ewan C., et al.
Publicado: (2020)

Testosterone Deficiency Is a Risk Factor for Severe COVID-19
por: Lanser, Lukas, et al.
Publicado: (2021)

COVID-19 and Molecular Genetics
por: Novelli, Giuseppe, et al.
Publicado: (2022)

Respiratory Care for Severe COVID-19
por: Prayag, Shirish
Publicado: (2020)

Air pollution and COVID-19 severity
por: Sunyer, Jordi, et al.
Publicado: (2023)

Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials
por: Mohiuddin, Md, et al.
Publicado: (2021)

Sparing of Severe Covid-19 in Vaccinated Adolescents
por: Edwards, Kathryn M.
Publicado: (2022)

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Risk Factors for Severe COVID-19 in a Large Medical Records Linkage System in the United States
por: Ishigami, Junichi
Publicado: (2021)

Increasing Awareness of the Low Risk of Severe Reaction at Infant Peanut Introduction: Implications During COVID-19 and Beyond
por: Abrams, Elissa M., et al.
Publicado: (2020)

Vitamin D’s Role in Reducing Risk of SARS-CoV-2 and COVID-19 Incidence, Severity, and Death
por: Grant, William B.
Publicado: (2021)

Does asthma affect morbidity or severity of COVID-19?
por: Matsumoto, Kenji, et al.
Publicado: (2020)

Why COVID-19 is Less Severe in Pediatric Patients?
por: Haileamlak, Abraham
Publicado: (2020)

COVID-19, severe mental illness, and family violence
por: Wildman, Emilie K., et al.
Publicado: (2021)

COVID-19 Severity and Cardiovascular Disease: An Inseparable Link
por: Henein, Michael Y., et al.
Publicado: (2022)

Severe COVID-19 and Stroke—Another Piece in the Puzzle*
por: Robinson, Christopher P., et al.
Publicado: (2021)

Is It Time to Revisit Remdesivir Use for Severe COVID-19?
por: Taggarsi, Dipali Anand
Publicado: (2022)

Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease
por: Raine, Tim, et al.
Publicado: (2015)

Editorial: The National COVID Cohort Collaborative Consortium Combines Population Data with Machine Learning to Evaluate and Predict Risk Factors for the Severity of COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Risk Perception and COVID-19
por: Cori, Liliana, et al.
Publicado: (2020)

Host Genetic Factors, Comorbidities and the Risk of Severe COVID-19
por: Zhu, Dongliang, et al.
Publicado: (2023)

Corticosteroids in severe COVID-19: a critical view of the evidence
por: De Backer, Daniel, et al.
Publicado: (2020)

How severe COVID-19 infection is changing ARDS management
por: Ferguson, Niall D., et al.
Publicado: (2020)

Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
por: Kashani, Kianoush B.
Publicado: (2020)

Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19
por: Hegyi, Péter, et al.
Publicado: (2020)

Biomarkers of biological age as predictors of COVID-19 disease severity
por: Lauc, Gordan, et al.
Publicado: (2020)

Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?
por: Hendren, Nicholas S., et al.
Publicado: (2021)

Potential therapeutic role of budesonide to reduce COVID-19 severity
por: Mohiuddin, Md, et al.
Publicado: (2022)

Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19
por: Shahridan Faiez, Tasnim, et al.
Publicado: (2022)

Treatment of severe covid-19 with interleukin 6 receptor inhibition
por: Rajasundaram, Skanda, et al.
Publicado: (2022)

Schizophrenia and COVID-19: risks and recommendations
por: Fonseca, Lais, et al.
Publicado: (2020)

TB/Covid-19: An Underestimated Risk?
por: Sotgiu, Giovanni, et al.
Publicado: (2022)

Genetics and Risk Assessment
por: Weier, H.-U.G., et al.
Publicado: (2012)

Is there a rationale for heparin use among severe COVID-19 patients?
por: Savioli, Felicio
Publicado: (2020)

Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned
por: Rodacki, Melanie
Publicado: (2020)

DPP-4 inhibitors and severe course of illness in patients with COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2021)

Timing of Endotracheal Intubation and Mortality among Patients with Severe COVID-19
por: Ray, Banambar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u37sdkv7ehvhspeajmhh0rq1h7